$TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Insider Trading Week 10/2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in TEVA PHARMACEUTICAL INDUSTRIES LTD.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in TEVA PHARMACEUTICAL INDUSTRIES LTD in week 10/2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 14 2018 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Option Exercise | M | 0.00 | 2,441 | 0 | 2,444 | |
| Mar 14 2018 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Sell | S | 19.20 | 2,441 | 46,867 | 2,974 | 5.4 K to 3 K (-45.08 %) |
| Mar 14 2018 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Buy | M | 0.00 | 2,441 | 0 | 5,415 | 3 K to 5.4 K (+82.08 %) |
| Mar 14 2018 | TEVA | TEVA PHARMACEUTICA ... | O'Grady Brendan P. | EVP, North America ... | Option Exercise | M | 0.00 | 738 | 0 | 738 | |
| Mar 14 2018 | TEVA | TEVA PHARMACEUTICA ... | O'Grady Brendan P. | EVP, North America ... | Sell | S | 19.49 | 738 | 14,383 | 1,388 | 2.1 K to 1.4 K (-34.71 %) |
| Mar 14 2018 | TEVA | TEVA PHARMACEUTICA ... | O'Grady Brendan P. | EVP, North America ... | Buy | M | 0.00 | 738 | 0 | 2,126 | 1.4 K to 2.1 K (+53.17 %) |
| Mar 14 2018 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, Growth Markets ... | Option Exercise | M | 0.00 | 880 | 0 | 883 | |
| Mar 14 2018 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, Growth Markets ... | Sell | S | 19.50 | 461 | 8,989 | 5,331 | 5.8 K to 5.3 K (-7.96 %) |
| Mar 14 2018 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, Growth Markets ... | Buy | M | 0.00 | 880 | 0 | 5,792 | 4.9 K to 5.8 K (+17.92 %) |
| Mar 14 2018 | TEVA | TEVA PHARMACEUTICA ... | Griffin Deborah A | Chief Accounting Of ... | Option Exercise | M | 0.00 | 952 | 0 | 953 | |
| Mar 14 2018 | TEVA | TEVA PHARMACEUTICA ... | Griffin Deborah A | Chief Accounting Of ... | Sell | S | 19.49 | 952 | 18,554 | 0 | 952 to 0 (-100.00 %) |
| Mar 14 2018 | TEVA | TEVA PHARMACEUTICA ... | Griffin Deborah A | Chief Accounting Of ... | Buy | M | 0.00 | 952 | 0 | 952 | 0 to 952 |
| Mar 14 2018 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Option Exercise | M | 0.00 | 1,190 | 0 | 1,191 | |
| Mar 14 2018 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Sell | S | 19.49 | 576 | 11,226 | 3,837 | 4.4 K to 3.8 K (-13.05 %) |
| Mar 14 2018 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Buy | M | 0.00 | 1,190 | 0 | 4,413 | 3.2 K to 4.4 K (+36.92 %) |
| Mar 14 2018 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Option Exercise | M | 0.00 | 714 | 0 | 715 | |
| Mar 14 2018 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Sell | S | 19.50 | 714 | 13,922 | 0 | 714 to 0 (-100.00 %) |
| Mar 14 2018 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Buy | M | 0.00 | 714 | 0 | 714 | 0 to 714 |